Home > Insider Trading > Filing (0001093557-22-000016)

Filing Details

Accession Number:: 0001093557-22-000016
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2022-02-14 17:06:06
Reporting Period:: 2022-02-10

Accepted Time:: 2022-02-14 17:06:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1093557	Dexcom Inc	DXCM	Surgical & Medical Instruments & Apparatus (3841)	330857544

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1520391	Barbara Kahn	6340 Sequence Drive San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2022-02-10	100	$428.55	7,566	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	100	$430.06	7,466	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	100	$435.64	7,366	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	100	$438.21	7,266	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	200	$440.85	7,066	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	476	$442.18	6,590	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	1,147	$434.36	5,443	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	443	$443.56	5,000	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	400	$444.80	4,600	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	200	$445.85	4,400	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	200	$447.35	4,200	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	400	$448.98	3,800	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	200	$450.07	3,600	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	200	$451.29	3,400	No	4	S	Indirect	by Trust
Common Stock	Disposition	2022-02-10	400	$452.50	3,000	No	4	S	Indirect	by Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust
No	4	S	Indirect	by Trust

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	918	Direct

Footnotes

On November 12, 2021, Ms. Kahn adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Ms. Kahn. The exercise and sale of shares set forth above were pursuant to the 10b5-1 Plan.
Represents 918 restricted stock units which were granted on May 21, 2021 and will vest on the earlier of the one year anniversary of the grant date or the date of DexCom Inc's 2022 Annual Meeting.
This transaction was executed in multiple trades at prices ranging from $440.65 to $441.04. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
his transaction was executed in multiple trades at prices ranging from $441.69 to $442.66. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $434.28 to $434.84. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $442.93 to $443.89. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $444.35 to $445.05. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
his transaction was executed in multiple trades at prices ranging from $445.54 to $446.15. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $447.06 to $447.64. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $448.53 to $449.47. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $449.61 to $450.52. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $450.96 to $451.61. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
This transaction was executed in multiple trades at prices ranging from $451.96 to $452.94. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.